These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6831042)

  • 1. Lysis of leukemia and lymphoma cells by autologous and allogeneic interferon-activated blood mononuclear cells.
    Oshimi K; Oshimi Y; Motoji T; Kobayashi S; Mizoguchi H
    Blood; 1983 Apr; 61(4):790-8. PubMed ID: 6831042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells.
    Oshimi K; Oshimi Y; Akutsu M; Takei Y; Saito H; Okada M; Mizoguchi H
    Blood; 1986 Oct; 68(4):938-48. PubMed ID: 3489494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of keratinocytes by IL-2-activated peripheral blood lymphocytes.
    Symington FW; Santos EB
    J Invest Dermatol; 1991 Jan; 96(1):127-33. PubMed ID: 1987288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of lymphoma cells by autologous and allogeneic natural killer cells.
    Oshimi K; Oshimi Y; Yamada O; Mizoguchi H
    Blood; 1985 Mar; 65(3):638-43. PubMed ID: 2578838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
    Uharek L; Zeis M; Glass B; Steinmann J; Dreger P; Gassmann W; Schmitz N; Müller-Ruchholtz W
    Leukemia; 1996 Nov; 10(11):1758-64. PubMed ID: 8892679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells.
    Shimazaki C; Atzpodien J; Wisniewski D; Gulati SC; Kolitz JE; Fried J; Clarkson BD
    Acta Haematol; 1988; 80(4):203-9. PubMed ID: 3146198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of lymphoma cells by cultured large granular lymphocytes.
    Oshimi K; Oshimi Y; Naohara T; Mizoguchi H
    Exp Hematol; 1985 Dec; 13(11):1192-6. PubMed ID: 3877647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphocyte cytotoxicity against autologous tumor cells and the effect of interferon-beta on their activities. (1) Evaluation by modification of target tumor cells].
    Ezaki K; Ito N; Suzuki M; Maruyama F; Kojima H; Sobue R; Matsui T; Ino T; Hirano M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1240-5. PubMed ID: 3495240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
    Cervantes F; Pierson BA; McGlave PB; Verfaillie CM; Miller JS
    Blood; 1996 Mar; 87(6):2476-85. PubMed ID: 8630414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes.
    Oshimi K; Oshimi Y; Satake M; Mizoguchi H
    J Exp Med; 1985 Aug; 162(2):472-86. PubMed ID: 3874925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peripheral blood monocytes are susceptible to interferon-activated natural killer cells.
    Einhorn S; Anderbring E
    J Clin Lab Immunol; 1985 Apr; 16(4):197-9. PubMed ID: 4020850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hairy cell leukemia cells are relatively NK-insensitive targets.
    Starling GC; Nimmo JC; Hart DN
    Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia.
    Hauch M; Gazzola MV; Small T; Bordignon C; Barnett L; Cunningham I; Castro-Malaspinia H; O'Reilly RJ; Keever CA
    Blood; 1990 Jun; 75(11):2250-62. PubMed ID: 2189508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine activated killing of fresh human leukaemias.
    Dawson MM; Johnston D; Taylor GM; Moore M
    Leuk Res; 1986; 10(6):683-8. PubMed ID: 3487007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
    Chong AS; Scuderi P; Grimes WJ; Hersh EM
    J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of purified Leu 19+ cells from the peripheral blood of children with acute lymphocytic leukemia.
    Afify ZA; Abdel-Mageed A; Findley HW; Ragab AH
    Cancer; 1990 Aug; 66(3):469-73. PubMed ID: 1694716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.